The Navy is prosecuting a sailor accused of using and distributing LSD, cocaine and many other drugs in San Diego.
Operations Specialist Seaman Jean Marc Riveracaban, of the amphibious assault ship Makin Island, is scheduled to go to a court-martial trial in November, officials told Navy Times.
He not only allegedly used and distributed narcotics between January and June but also brought them on to Naval Base San Diego, according to his charge sheets.
And the Navy began investigating only after Riveracaban popped positive on a urinalysis test, according to Navy Region Southwest spokesman Brian O’Rourke.
RELATED
![](https://www.armytimes.com/resizer/v2/HIYCEN4VWZF2NIK2U2C643WVXU.jpg?auth=8ec615463ef5c60dd7631944bb562ade45e2319c57e2ad96f3290938590a6841&width=768&height=602)
Prosecutors accuse Riveracaban of the “wrongful use” of cocaine, marijuana, oxycodone, hydrocodone, morphine, Xanax, LSD and fentanyl, according to the charge sheets.
They say he also brought cocaine, fentanyl and LSD onto Naval Base San Diego in the first six months of this year to distribute the drugs.
Riveracaban could not be reached for comment and his military attorney did not return requests for comment submitted through public affairs officers.
Originally from Puerto Rico, Riveracaban enlisted in 2016 and reported to the Makin Island in early 2018, according to his service records.
Before that, he spent roughly four months assigned to Helicopter Sea Combat Squadron 3, service records show.
His first assignment out of school was to the amphibious assault ship America, where he was stationed from January 2017 to September 2017, according to records.
RELATED
![](https://www.armytimes.com/resizer/v2/RYX4GTAOEJCLVFYQU6WJTF6E3U.jpg?auth=af3b6e668284f0d39e8f48d80b5e6eb34ee086b2ccf835d7847538c2c73de3a0&width=1200&height=600)
Geoff is the managing editor of Military Times, but he still loves writing stories. He covered Iraq and Afghanistan extensively and was a reporter at the Chicago Tribune. He welcomes any and all kinds of tips at geoffz@militarytimes.com.